Atezolizumab vs Imatinib

## Atezolizumab vs Imatinib: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Imatinib**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Imatinib — 18 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Imatinib — C29H31N7O.

**Molecular Weight**: Atezolizumab — N/A; Imatinib — 493.6030 g/mol.

**Type**: Atezolizumab — Antibody; Imatinib — Small molecule.